Company profile
HealthLynked Corp.
OTC: HLYK · Healthcare · Medical - Care Facilities
#790 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
34DFH 32DQ 35GM 38SS 39
v0.1 · 65/100 weight · provisional
↑ growth stability, Piotroski F · ↓ balance-sheet leverage, Altman-Z
Methodology →Revenue TTM
$1.7M
Rev growth YoY (TTM)
-38.3%
Net income (FY)
-$3.3M
Employees
10
as of 2026-08-22
Market cap
$8.1M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.1M$2.1M2025
Net income-$3.3M-$3.3M2025
Operating income-$2.1M-$2.1M2025
Total assets$1.7M$1.7M2025
Liabilities$7.5M$7.5M2025
Equity-$5.8M-$5.8M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY25
FY25
Revenue by segment
Filed disclosures · FY2022
By product
ACOMCOMember100%
By geography
Not disclosed.
The read
What is HealthLynked Corp.’s revenue?
HealthLynked Corp. booked $2.1M in FY2025 revenue, contracting 31% year over year — slower than 76% of Healthcare companies we track, at a -158.8% net margin.
Peers · Healthcare
GeneLink, Inc.——Aeolus Pharmaceuticals, Inc.——Cyclerion Therapeutics, Inc.40D20/20 Biolabs Inc.29DHumacyte, Inc.27DNutriband Inc.52DNeighbors
Collier →Key facts
CEOMichael Thomas Dent
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersNaples, FL
ExchangeOTC: HLYK
Employees10
IPO date2017-05-05
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.